These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 18222378)
21. A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Zavagno G; De Salvo GL; Scalco G; Bozza F; Barutta L; Del Bianco P; Renier M; Racano C; Carraro P; Nitti D; Ann Surg; 2008 Feb; 247(2):207-13. PubMed ID: 18216523 [TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node metastases detected by immunohistochemistry only do not mandate complete axillary lymph node dissection in breast cancer. Gray RJ; Pockaj BA; Conley CR Ann Surg Oncol; 2004 Dec; 11(12):1056-60. PubMed ID: 15545503 [TBL] [Abstract][Full Text] [Related]
23. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit. Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346 [TBL] [Abstract][Full Text] [Related]
24. Non-sentinel lymph node status and prognosis of breast cancer patients with micrometastatic sentinel lymph nodes. Onishi T; Jinno H; Takahashi M; Hayashida T; Sakata M; Nakahara T; Shigematsu N; Mukai M; Kitagawa Y Eur Surg Res; 2010; 45(3-4):344-9. PubMed ID: 21088425 [TBL] [Abstract][Full Text] [Related]
25. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy. Gur AS; Unal B; Johnson R; Ahrendt G; Bonaventura M; Gordon P; Soran A J Am Coll Surg; 2009 Feb; 208(2):229-35. PubMed ID: 19228534 [TBL] [Abstract][Full Text] [Related]
26. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507 [TBL] [Abstract][Full Text] [Related]
27. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND. Goyal A; Newcombe RG; Chhabra A; Mansel RE Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117 [TBL] [Abstract][Full Text] [Related]
28. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years. Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841 [TBL] [Abstract][Full Text] [Related]
29. The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram. Cripe MH; Beran LC; Liang WC; Sickle-Santanello BJ Am J Surg; 2006 Oct; 192(4):484-7. PubMed ID: 16978955 [TBL] [Abstract][Full Text] [Related]
30. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system. Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A Breast J; 2006; 12(4):294-301. PubMed ID: 16848838 [TBL] [Abstract][Full Text] [Related]
31. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure. Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M Breast Cancer Res Treat; 2009 Nov; 118(2):385-94. PubMed ID: 19562480 [TBL] [Abstract][Full Text] [Related]
32. Accuracy of intraoperative imprint cytology of sentinel lymph nodes in breast cancer. Pugliese MS; Kohr JR; Allison KH; Wang NP; Tickman RJ; Beatty JD Am J Surg; 2006 Oct; 192(4):516-9. PubMed ID: 16978964 [TBL] [Abstract][Full Text] [Related]
33. Influence of frozen-section analysis of sentinel lymph node and lumpectomy margin status on reoperation rates in patients undergoing breast-conservation therapy. McLaughlin SA; Ochoa-Frongia LM; Patil SM; Cody HS; Sclafani LM J Am Coll Surg; 2008 Jan; 206(1):76-82. PubMed ID: 18155571 [TBL] [Abstract][Full Text] [Related]
34. The clinical significance of axillary lymph node micrometastases in breast cancer. Sakorafas GH; Geraghty J; Pavlakis G Eur J Surg Oncol; 2004 Oct; 30(8):807-16. PubMed ID: 15336724 [TBL] [Abstract][Full Text] [Related]
35. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Chen SL; Hoehne FM; Giuliano AE Ann Surg Oncol; 2007 Dec; 14(12):3378-84. PubMed ID: 17899293 [TBL] [Abstract][Full Text] [Related]
36. Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer. Noguchi M Eur J Surg Oncol; 2008 Feb; 34(2):129-34. PubMed ID: 17498911 [TBL] [Abstract][Full Text] [Related]
37. [Critical study of our initial experience of 993 sentinel node biopsies for breast surgery]. Martel P; Capdet J; Méry E; Zerdoud S; Ferron G; Rafii A; Roché H; Querleu D Bull Cancer; 2008; 95(7):763-72. PubMed ID: 18755653 [TBL] [Abstract][Full Text] [Related]
38. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma. Sakr R; Antoine M; Barranger E; Dubernard G; Salem C; Daraï E; Uzan S Breast J; 2008; 14(1):55-60. PubMed ID: 18186866 [TBL] [Abstract][Full Text] [Related]
39. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study. Bulte CS; van der Heiden-van der Loo M; Hennipman A Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809 [TBL] [Abstract][Full Text] [Related]
40. Factors associated with involvement of four or more axillary nodes for sentinel lymph node-positive patients. Katz A; Niemierko A; Gage I; Evans S; Shaffer M; Smith FP; Taghian A; Magnant C Int J Radiat Oncol Biol Phys; 2006 May; 65(1):40-4. PubMed ID: 16488555 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]